New Zealand markets open in 6 hours 53 minutes

PT Kalbe Farma Tbk. (KLBF.JK)

Jakarta - Jakarta Delayed price. Currency in IDR
Add to watchlist
1,780.00-35.00 (-1.93%)
At close: 04:09PM WIB

PT Kalbe Farma Tbk.

Gedung KALBE
Jl. Let. Jend. Suprapto Kav. 4 Cempaka Putih
Jakarta 10510
62 21 4287 3888

IndustryDrug Manufacturers—General
Full-time employees13,165

Key executives

NameTitlePayExercisedYear born
Mr. - VidjongtiusPres DirectorN/AN/A1964
Mr. Lukito Kurniawan GozaliHead of Investor Relations & Corp. Sec.N/AN/A1979
Ms. Lanny SoputroDirector of HR, Gen. Affairs & HSSEN/AN/A1964
Mr. Kurniawan SuhartonoHead of Internal Audit UnitN/AN/A1965
Mr. Sie DjohanDirector of Corp. Bus. Devel., Management System & Regulatory Affairs and DirectorN/AN/A1967
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in IDR.


PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Corporate governance

PT Kalbe Farma Tbk.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.